A phase II randomized, double-mask study to establish the safety and efficacy of high-dose oral omega 3 in subjects with geographic atrophy secondary to dry age-related macular degeneration

The objectives of this study are to evaluate the safety and efficacy of High-Dose Oral Omega 3 on the Photoreceptors/Retinal Pigment Epithelium/Bruch’s membrane complex in subjects with geographic atrophy secondary to age-related macular degeneration and to evaluate whether improvement in visual function occurs and progression to advanced stages of AMD is delayed.